This inventor holds 3 USPTO granted patents and 6 published patent applications and 3 EPO patents. Top assignees: Small Lab Co., Ltd., Hugel Inc.. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2020
Title: Jeong Gyu Lee: Innovator in Microstructure Formulation Techniques
Introduction
Jeong Gyu Lee is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of medical technology, particularly in the formulation techniques for botulinum toxin. With a total of 3 patents to his name, his work is poised to enhance the safety and efficacy of medical procedures involving botulinum toxin.
Latest Patents
One of Jeong Gyu Lee's latest patents focuses on microstructure formulation techniques for botulinum toxin. This invention allows for precise control over the concentration of botulinum toxin, which is crucial for minimizing pain during administration. Additionally, it enables accurate delivery of the toxin to targeted areas within the human body. The implications of this invention are significant, as it is expected to greatly improve the safe and convenient medical use of botulinum toxin.
Career Highlights
Throughout his career, Jeong Gyu Lee has worked with various companies, including Small Lab Co., Ltd. and Hugel Inc. His experience in these organizations has contributed to his expertise in the field of medical innovations.
Collaborations
Jeong Gyu Lee has collaborated with notable colleagues such as Kyeong Yeop Moon and Chang Jin Lee. These partnerships have likely enriched his research and development efforts, leading to advancements in his patented technologies.
Conclusion
In summary, Jeong Gyu Lee is a prominent inventor whose work in microstructure formulation techniques for botulinum toxin is set to make a lasting impact on medical practices. His innovative approach promises to enhance patient safety and treatment outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile